The drug industry is scrambling to bring psychedelic medicines to the market after Australia became the first country to approve their use, with one company offering free MDMA-assisted therapy to first responders. MDMA is commonly known as Ecstasy. While previous clinical studies have shown promising signs, researchers have highlighted potential risks as the drug begins to roll out more broadly.